SCHEMBL8658144

SCHEMBL8658144

CCCCC1(CC)NC(SCc2ccccc2N(C)C)=NC1=O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.33
ATP4A P20648 1/20 0.31
ATP4B P51164 1/20 0.31
CTSB P07858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656860 0.91 AR (0.36) ARATP4AATP4B
SCHEMBL8655331 0.89 AR (0.35) ARATP4AATP4B
SCHEMBL8658153 0.82 AR (0.36) ARATP4AATP4B
SCHEMBL8654182 0.79 LMNA (0.33) ARATP4AATP4B
SCHEMBL8654394 0.79 AR (0.38) ARATP4AATP4B
Hydrochloric Acid SCHEMBL8656854 0.78 AR (0.37) ARATP4AATP4B
SCHEMBL8655775 0.78 CYP2C19 (0.38) ARATP4AATP4B
SCHEMBL8656613 0.76 AR (0.36) ARATP4AATP4B
SCHEMBL8656716 0.74 AR (0.34) ARATP4AATP4B
SCHEMBL8658166 0.74 AR (0.39) ARATP4AATP4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5733922-A Imidazole derivative, pharmaceutically acceptable salt thereof, and anti-ulcer drug including such derivative or salt ARAX CO., LTD. (JP) 1998-03-31 US disclosed
EP-0728747-A1 Imidazole derivative, pharmaceutically acceptable salt thereof, process of manufacture therefor, and anti-ulcer drug including such derivative or salt ARAX CO., LTD. (JP) 1996-08-28 EP disclosed